Search This Blog

Monday, August 10, 2020

Eagle Pharmaceuticals EPS beats by $0.34, misses on revenue August 10, 2020

Eagle Pharmaceuticals (NASDAQ:EGRX): Q2 Non-GAAP EPS of $0.57 beats by $0.34; GAAP EPS of -$0.02 beats by $0.30.
Revenue of $41.94M (-26.0% Y/Y) misses by $0.29M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)